Michael Barbella, Managing Editor05.31.23
Shore Capital Partners has sold Innovia Medical to Inverness Graham, a Philadelphia-based buyout firm that acquires innovative, high-growth businesses. Terms of the deal were not disclosed.
Shore Capital formed Innovia Medical through the initial acquisitions of Summit Medical Inc. in February 2015, and Shippert Medical Enterprises LLC in October 2015. Shore appointed long-time healthcare operator Terry Meredith as Innovia's CEO, and he led the company's expansion by acquiring six additional businesses, thereby bolstering the platform’s strategic positioning, product portfolio, and customer reach. Innovia Medical currently is a global provider of single-use surgical essentials and sterile processing products with a manufacturing footprint in the United States and United Kingdom.
“Innovia’s success to date can be attributed to the strong alignment of the platform’s founders and employees with the strategic direction that Terry expertly led,” Shore Capital Partner and Innovia Board Chairman Don Pierce said. “We are pleased to have supported the development of Innovia into one of the leading medical device platforms in the specialty surgical market, and we believe that the company is well-positioned for continued growth.”
The transaction closed earlier this spring. Piper Sandler & Co. served as financial advisor to Innovia and Winston & Strawn LLP served as legal advisor to Shore Capital and Innovia on the transaction. Faegre Drinker Biddle & Reath LLP served as legal advisor to Inverness Graham.
“Our partnership with Shore has been invaluable,” Meredith stated. “The firm was integral to our growth strategy, helping to build Innovia into a global provider of sought-after brands, ultimately improving outcomes for the patients we serve. We are excited about our next chapter and look forward to capturing future growth opportunities in partnership with Inverness Graham.”
Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, Tenn., is focused on microcap investments within the healthcare, food and beverage, business services, and real estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles.
Innovia is a family of specialty surgical companies that partner with medical professionals to help elevate patient care delivery and improve clinical outcomes. Innovia has built a diverse portfolio of 550 products backed by strong intellectual property and supplies medical products to facilities in more than 70 countries.
Shore Capital formed Innovia Medical through the initial acquisitions of Summit Medical Inc. in February 2015, and Shippert Medical Enterprises LLC in October 2015. Shore appointed long-time healthcare operator Terry Meredith as Innovia's CEO, and he led the company's expansion by acquiring six additional businesses, thereby bolstering the platform’s strategic positioning, product portfolio, and customer reach. Innovia Medical currently is a global provider of single-use surgical essentials and sterile processing products with a manufacturing footprint in the United States and United Kingdom.
“Innovia’s success to date can be attributed to the strong alignment of the platform’s founders and employees with the strategic direction that Terry expertly led,” Shore Capital Partner and Innovia Board Chairman Don Pierce said. “We are pleased to have supported the development of Innovia into one of the leading medical device platforms in the specialty surgical market, and we believe that the company is well-positioned for continued growth.”
The transaction closed earlier this spring. Piper Sandler & Co. served as financial advisor to Innovia and Winston & Strawn LLP served as legal advisor to Shore Capital and Innovia on the transaction. Faegre Drinker Biddle & Reath LLP served as legal advisor to Inverness Graham.
“Our partnership with Shore has been invaluable,” Meredith stated. “The firm was integral to our growth strategy, helping to build Innovia into a global provider of sought-after brands, ultimately improving outcomes for the patients we serve. We are excited about our next chapter and look forward to capturing future growth opportunities in partnership with Inverness Graham.”
Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, Tenn., is focused on microcap investments within the healthcare, food and beverage, business services, and real estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles.
Innovia is a family of specialty surgical companies that partner with medical professionals to help elevate patient care delivery and improve clinical outcomes. Innovia has built a diverse portfolio of 550 products backed by strong intellectual property and supplies medical products to facilities in more than 70 countries.